The primal, upsetting forces that lead to art also hold the power to decimate mental stability. Such is the paradox in John Olive's intriguing 1982 study of a published minor poetess, Catherine (Meg Wallace), struggling with prescription Thorazine for schizophrenia. The drug may keep the demons at bay, but it similarly bars the inspiration that gives Catherine's poetry its flight. The play begins in Catherine's "artist garret" bedroom as she's recovering from a breakdown. It then takes us through her plateau of comparative normality including a desk job offered to Catherine by her pushy publisher, Alice (Rachel Hardy) and a kind of artistic stagnation that leads to her defying her doctor's (Barbara Keegan) orders by cutting back on the drug, and consequently careening toward another breakdown. Through this, she engages in a doomed romance with a smitten, bewildered stockbroker (Nathan Van Williams) an affair that more or less defines the play's trajectory. Act 1 is a long setup with scant dramatic action that hangs (barely) on exposition about the big "S" disease, symptoms of which are muted by the Thorazine. In Act 2, hell breaks loose, which justifies the wait. Wallace's quality of demure sweetness yields to bouts of rabid hostility and implosions of confidence, matched by Van Williams' kindly incomprehension of just about everything that means something to Catherine, from her love of dissonant classical music to the flows of dark energy that drive her poetry. As the publisher, Hardy pushes Alice's pushiness like a broom clearing the path of her ambitions more plausible than textured. Nice turn by Keegan as the shrink who, under Trace Oakley's direction, gingerly negotiates the transformation from every Lifetime movie shrink into an elfin cartoon from some Christopher Durang farce a figment of Catherine's tortured imagination. Oakley's basic staging contains no bravura performances, yet it's capable enough to hold its own. Fridays, Saturdays, 8 p.m. Starts: Jan. 11. Continues through Feb. 16, 2008
Recommended For YouPowered by SailThru
If you like this story, consider signing up for our email newsletters.
SHOW ME HOW
You have successfully signed up for your selected newsletter(s) - please keep an eye on your mailbox, we're movin' in!